Innovative strategies to treat chronic viral infections after hematopoietic stem…
Identify, measure or monitor biological signals linked to response or progression.
Offer overview
What this offer helps you achieve
Identify, measure or monitor biological signals linked to response or progression.
Scientific and technical scope
A network, a cohort and a prospective biobank to tackle persistent viral infections in transplanted patients and to develop innovative diagnoses and therapeutic strategies . Aims : To improve virological and immunological monitoring, to identify new targets and screen antiviral molecules, to improve access to and efficacy of new therapies, to set up prospective cohorts, biobanks & clinical trials Coordination: Jérôme Le Goff - Leaders: Sophie Caillat-Zucman, Jean Roch Fabreguettes, Jean Hugues Dalle, Jean-Michel Molina, Julien Zuber, Ali Amara, Sylvie Chevret Stage : Translational research of the Hospital-University Federation TRANSVIR recognized in 2025 by INSERM, AP-HP, Université Paris Cité : Adoptive Cell therapies (NK Cells, Cytotoxic T Cell against BKV, HAdV), Oligo Antisens therapies, Diagnosis & Monitoring, Clinical Management and Evaluation
Capabilities mobilised
Expert adviceTherapeutic target discoveryBiomarkersReal-life monitoringBiotesting
Application fields
Discuss this offer
Could this capability strengthen your R&D programme?
Present your scientific, technical or clinical need and identify the most relevant route to collaboration.
Continue exploring
Related expertise for your programme
Offers selected through shared capabilities, application fields or institute expertise.
